Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
3
×
life sciences
national blog main
clinical trials
medical device
startups
20/20 healthcare partners
480 biomedical
ally bridge group
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
arsenal medical
big data analytics
blackrock
bob langer
casdin capital
christian angermayer
chronic rhinosinusitis
covid-19
deals
diabetic nephropathy
dolby family ventures
drug delivery
enclear therapies
eventide asset management
fda
financing
focal segmental glomerulosclerosis
funding
genzyme
george whitesides
gf securities
global health sciences fund
goldfinch bio
hillel bachrach
inflammation
What
new
3
×
raised
3
×
biotech
company
develop
diseases
ipo
million
raises
analysis
associated
bio
bring
companies
debut
developing
device
dialysis
disease
drug
drugs
employing
enclear
genetic
goldfinch
harmful
kidney
late
later
lead
lyra
markets
medicines
nets
neuro
neurodegenerative
nose
noses
persistently
proteins
Language
unset
Current search:
raised
×
boston
×
" boston top stories "
×
new
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device